Evidence map›Paper›PMID 42005850›Full record

ArticleFrontiers in microbiology2026

Exploring the potential of oxymatrine in preventing CHIKV-induced acute kidney injury based on multi-dimensional computational analysis and

JiaLiang Xin, FangJun Li, LuLu Kang, Jie Yang, HaiTong Wang, Wei Wang, Sheng Feng, XinFei Liao, WenJie Li, He Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

JiaLiang Xin *Jilin Collaborative Innovation Center for Antibody Engineering, Jilin Medical University, Jilin, China.
FangJun Li *Jilin Collaborative Innovation Center for Antibody Engineering, Jilin Medical University, Jilin, China.
LuLu Kang *Wenzhou Municipal Center for Disease Control and Prevention, Wenzhou Municipal Institute of Health Supervision, Wenzhou, China.
Jie YangWenzhou Municipal Center for Disease Control and Prevention, Wenzhou Municipal Institute of Health Supervision, Wenzhou, China.
HaiTong WangJilin Collaborative Innovation Center for Antibody Engineering, Jilin Medical University, Jilin, China.
Wei WangWenzhou Municipal Center for Disease Control and Prevention, Wenzhou Municipal Institute of Health Supervision, Wenzhou, China.
Sheng FengJilin Collaborative Innovation Center for Antibody Engineering, Jilin Medical University, Jilin, China.
XinFei LiaoWenzhou Polytechnic, Wenzhou, China.
WenJie LiWenzhou Municipal Center for Disease Control and Prevention, Wenzhou Municipal Institute of Health Supervision, Wenzhou, China.
He ZhangChangchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chikungunya virus (CHIKV) infection can induce acute kidney injury (AKI) and may be fatal in severe cases, yet effective therapeutic strategies remain unclear. This study integrated computational analysis (network pharmacology and molecular docking) with

Indexed as

acute kidney injuryCHIKVferroptosisnetwork pharmacologyOxymatrine

Identifiers

PMID42005850
PMCPMC13083131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.